Drug Master Files for: Unimark Remedies Ltd
✉ Email this page to a colleague
Unimark Remedies Ltd Drug Master Files
| DMF No. | Status | Type | Submission Date | Holder | Subject |
|---|---|---|---|---|---|
| 17626 | A | II | 8/26/2004 | UNIMARK REMEDIES LTD | LISINOPRIL USP |
| 17754 | A | II | 11/8/2004 | UNIMARK REMEDIES LTD | ALBENDAZOLE USP |
| 18286 | A | II | 4/19/2005 | UNIMARK REMEDIES LTD | MELOXICAM USP |
| 18361 | I | II | 5/20/2005 | UNIMARK REMEDIES LTD | CEPHALEXIN USP |
| 19272 | A | II | 3/23/2006 | UNIMARK REMEDIES LTD | FLECAINIDE ACETATE USP |
| 19479 | A | II | 5/31/2006 | UNIMARK REMEDIES LTD | BENAZEPRIL HYDROCHLORIDE USP |
| >DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information
